NCT07228429
Quantification of Calcinosis Cutis Disease Burden Using Computed Tomography Images
At risk: Primary completion moved at least 9 months later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Primary and study completion pushed from Jul 2026 to May 2027
- Eligibility criteria expanded, about 6 words
- Secondary endpoints: details revised at 1 of 1 entry
Notable Trial status: Not Yet Recruiting to Recruitingv2 Show 4 more changesShow less
- Start date changed from estimate of Nov 2025 to Oct 14, 2025
- Interventions: Sodium Thiosulfate (STS) (Drug) to Sodium Thiosulfate (STS) (Drug), Sodium Thiosulfate Injection (Drug)
- Secondary endpoint revised
- Site details revised
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Modified Mawdsley Calcinosis Questionnaire (mMCQ)
Timeframe: Baseline, 3 months and 6 months
Calcinosis VAS
Timeframe: Baseline, 3 months and 6 months
CT imaging measure
Timeframe: Baseline, 3 months and 6 months
Secondary (1)
Correlation between the change in the mMCQ scores and the CT imaging measures
Arms and interventions
Systemic sclerosis participants with calcinosis
SSc participants with calcinosis treated with sodium thiosulfate STS per SOC over 6 months.
Drugs: Sodium Thiosulfate (STS), Sodium Thiosulfate Injection
Sites
1 site in 1 country
- Yale Scleroderma ProgramNew Haven, Connecticut, United States